Brief: China Biotech Services Holdings Says Indirect Unit Granted Letter Of Authorisation By Innovita
15/03/2020 18:53
March 16 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* INDIRECT UNIT PHC MEDICAL DIAGNOSTIC CENTRE LTD GRANTED
LETTER
OF AUTHORISATION BY INNOVITA
* UNIT TO IMPORT, SELL, COMMERCIALISE INNOVITA'S 2019-NCOV
AB TEST
IN HK, MACAU, JAPAN, US, CANADA, EU, SE ASIA, AUSTRALIA
* LETTER OF AUTHORISATION VALID FOR 6 MONTHS UNTIL SEPT 10,
2020
Source text for Eikon: urn:newsml:reuters.com:*:nHKS48pxc5
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)